Real-time Estimate Tradegate 08:47:11 2024-04-16 am EDT 5-day change 1st Jan Change
97.55 EUR -1.46% Intraday chart for Gerresheimer AG -9.39% +2.76%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
GERRESHEIMER AG : Deutsche Bank remains its Buy rating ZD
GERRESHEIMER AG : Berenberg gives a Buy rating ZD
GERRESHEIMER AG : Deutsche Bank reiterates its Buy rating ZD
GERRESHEIMER AG : Buy rating from JP Morgan ZD
Gerresheimer shares down on outlook, but key contracts confirmed RE
Barclays upgrades Gerresheimer to 'Overweight' - Target 125 euros DP
GERRESHEIMER AG : Barclays reiterates its Buy rating ZD
Gerresheimer continues to focus on recovery from the summer - share price falls DP
Gerresheimer very weak - Certain uncertainties about outlook DP
Gerresheimer supplies 'key players' in GLP-1 drugs market, CEO says RE
Transcript : Gerresheimer AG, Q1 2024 Earnings Call, Apr 11, 2024
GERRESHEIMER AG : Gets a Buy rating from Jefferies ZD
GERRESHEIMER AG : JP Morgan maintains a Buy rating ZD
Gerresheimer expects sales boost from burgeoning obesity drugs sector RE
Partially lower pharmaceutical demand slows down Gerresheimer - outlook confirmed DP
Gerresheimer AG Provides Earnings Guidance for the Year 2024 and 2025 CI
Gerresheimer AG Reports Earnings Results for the First Quarter Ended February 29, 2024 CI
GERRESHEIMER AG : Receives a Buy rating from JP Morgan ZD
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says RE
GERRESHEIMER AG : Deutsche Bank maintains a Buy rating ZD
GERRESHEIMER AG : Barclays keeps its Buy rating ZD
GERRESHEIMER AG : Berenberg reiterates its Buy rating ZD
GERRESHEIMER AG : Jefferies reiterates its Buy rating ZD
GERRESHEIMER AG : Gets a Buy rating from JP Morgan ZD
Gerresheimer under pressure - First quarter weak as announced DP
Chart Gerresheimer AG
More charts
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
99 EUR
Average target price
132.5 EUR
Spread / Average Target
+33.81%
Consensus
  1. Stock Market
  2. Equities
  3. GXI Stock
  4. News Gerresheimer AG
  5. Gerresheimer : FY20 Net Income Rises, Forecasts EPS Growth Of 10% In 2021